Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Gong, Tingyu  [Clear All Filters]
Journal Article
Gong T, Wang H, Huang B, Wang H, Zhang P, Qian J. Corrigendum to "Reprogramming of human peripheral blood mononuclear cells from a patient suffering from recurrent hydatidiform mole to an iPSC line FAHZUi001-A carrying a homozygous p.Gln421Ter mutation in NLRP7 gene" [Stem Cell Res. 53 (2021) 102361]. Stem Cell Res. 2021;55:102479.
Sun Y, Zhou J, Wang H, Wang H, Chen X, Gong T, Liang P, Jiang C. Establishment of an induced pluripotent stem cell line (ZJULLi004-A) from a hypertrophic cardiomyopathy patient carrying MYBPC3/c.3764C>A mutation. Stem Cell Res. 2022;64:102898.
Cao Y, Tang L, Su J, Wang H, Liang P, Rong K, Gong T. Generation of a TRPV1 knockout human pluripotent stem cell line (WAe009-A-U) using CRISPR/Cas9. Stem Cell Res. 2023;72:103202.
Zhou D, Sun Y, Shen J, Su J, Gong T, Jiang C, Liang P. Generation of an induced pluripotent stem cell line from the dermal fibroblasts of a patient with arrhythmogenic right ventricular cardiomyopathy carrying a PKP2/c.2489 + 1G > A mutation. Stem Cell Res. 2020;48:101965.
Zhou J, Sun Y, Wang H, Wang H, Guo F, Chen X, Gong T, Jiang C, Liang P. Generation of an induced pluripotent stem cell line (ZJULLi003-A) from a hypertrophic cardiomyopathy patient carrying MYH7/c.4384G > A mutation. Stem Cell Res. 2022;64:102883.
Wang J, Su J, Gong T, Li T, Shen J, Wang H, Xie H, Zhou L, Zheng S, Liang P. Generation of ZJUi003-A, an induced pluripotent stem cell line from a Wilson's disease patient carrying a c.180_181del mutation in ATP7B gene. Stem Cell Res. 2020;46:101873.
Tang L, Wang H, Dai B, Wang X, Zhou D, Shen J, Guo F, Wang J, Zhou J, Wang H, et al. Human induced pluripotent stem cell-derived cardiomyocytes reveal abnormal TGFβ signaling in type 2 diabetes mellitus. J Mol Cell Cardiol. 2020.
Qiu H, Sun Y, Pan Z, Zhou J, Wang H, Wang X, Cai D, Fu G, Gong T, Jiang C, et al. Inhibition of HSC70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell-derived cardiomyocytes with a MYBPC3 mutation. Clin Transl Med. 2021;11(12):e647.
Tang L, Yao F, Wang H, Wang X, Shen J, Dai B, Wu H, Zhou D, Guo F, Wang J, et al. Inhibition of TRPC1 prevents cardiac hypertrophy via NF-κB signaling pathway in human pluripotent stem cell-derived cardiomyocytes. J Mol Cell Cardiol. 2018.
Zhou J, Cui B, Wang X, Wang H, Zheng J, Guo F, Sun Y, Fan H, Shen J, Su J, et al. Overexpression of KCNJ2 enhances maturation of human-induced pluripotent stem cell-derived cardiomyocytes. Stem Cell Res Ther. 2023;14(1):92.
Cai D, Wang X, Sun Y, Fan H, Zhou J, Yang Z, Qiu H, Wang J, Su J, Gong T, et al. Patient-specific iPSC-derived cardiomyocytes reveal aberrant activation of Wnt/β-catenin signaling in SCN5A-related Brugada syndrome. Stem Cell Res Ther. 2023;14(1):241.
Sun Y, Su J, Wang X, Wang J, Guo F, Qiu H, Fan H, Cai D, Wang H, Lin M, et al. Patient-specific iPSC-derived cardiomyocytes reveal variable phenotypic severity of Brugada syndrome. EBioMedicine. 2023;95:104741.
Zhou D, Tan Y, Liu X, Tang L, Wang H, Shen J, Wang W, Zhuang L, Tao J, Su J, et al. Patient-specific iPSC-derived endothelial cells reveal aberrant p38 MAPK signaling in atypical hemolytic uremic syndrome. Stem Cell Reports. 2021.